Manifestaciones tóxicas producidas por el methotrexato en la leucemia aguda linfoblástica

Svarch, Eva; Torres Montejo, Ernesto de la; Cabrera Arregoitia, Jesús; Vázquez, Belkis.
Rev. cuba. pediatr ; 44(4,5,6): 259-264, jul.-dic.1972. tab
Artículo en Español | CUMED | ID: cum-25557

Documentos relacionados

  1. New Therapeutic Approach to Reduce Methotrexate Toxicity after High-Dose Chemotherapy in a Child with Acute Lymphocytic Leukemia: Efficacy and Safety of Hemoadsorption with HA-230 Adsorber.
  2. Dose-individualization Efficiently Maintains Sufficient Exposure to Methotrexate without Additional Toxicity in High-dose Methotrexate Regimens for Pediatric Acute Lymphoblastic Leukemia.
  3. Inhibition of methotrexate induced toxicity in the adult rat spleen by adalimumab.
  4. Rescuing effect of folates on methotrexate cytotoxicity in human trophoblast cells.
  5. A systematic review and meta-analysis of MTHFR polymorphisms in methotrexate toxicity prediction in pediatric acute lymphoblastic leukemia.
  6. Predicting delayed methotrexate elimination in pediatric acute lymphoblastic leukemia patients: an innovative web-based machine learning tool developed through a multicenter, retrospective analysis.
  7. Amelioration of Bleomycin and Methotrexate-Induced Pulmonary Toxicity by Serratiopeptidase and Fisetin.
  8. Population Pharmacokinetic Model of Methotrexate in Brazilian Pediatric Patients with Acute Lymphoblastic Leukemia.
  9. Role of IL-6/STAT3 pathway in mediating the protective effect of agomelatine against methotrexate-induced lung/intestinal tissues damage in rats.
  10. Methotrexate toxicity in psoriasis-A multicentric retrospective study.